These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1662627

  • 21. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
    Putnam SD, Castanheira M, Moet GJ, Farrell DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
    [Abstract] [Full Text] [Related]

  • 22. Antibacterial profile of flurithromycin, a new macrolide.
    Saverino D, Debbia EA, Pesce A, Lepore AM, Schito GC.
    J Antimicrob Chemother; 1992 Sep; 30(3):261-72. PubMed ID: 1452490
    [Abstract] [Full Text] [Related]

  • 23. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method.
    Bradford PA, Petersen PJ, Young M, Jones CH, Tischler M, O'Connell J.
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3903-9. PubMed ID: 16127069
    [Abstract] [Full Text] [Related]

  • 24. In-vitro comparison of roxithromycin and erythromycin against 900 anaerobic bacterial strains.
    Dubreuil L.
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():13-9. PubMed ID: 3429381
    [Abstract] [Full Text] [Related]

  • 25. Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum.
    Pruul H, McDonald PJ.
    Antimicrob Agents Chemother; 1992 Jan; 36(1):10-6. PubMed ID: 1317141
    [Abstract] [Full Text] [Related]

  • 26. In vitro effects of azithromycin on Salmonella typhi: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula.
    Butler T, Frenck RW, Johnson RB, Khakhria R.
    J Antimicrob Chemother; 2001 Apr; 47(4):455-8. PubMed ID: 11266420
    [Abstract] [Full Text] [Related]

  • 27. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH, Friedel HA, McTavish D.
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
    Chin NX, Neu HC.
    Am J Med; 1987 Apr 27; 82(4A):58-62. PubMed ID: 3578330
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The comparative in-vitro activity of ofloxacin.
    Grüneberg RN, Felmingham D, O'Hare MD, Robbins MJ, Perry K, Wall RA, Ridgway GL.
    J Antimicrob Chemother; 1988 Sep 27; 22 Suppl C():9-19. PubMed ID: 3182468
    [Abstract] [Full Text] [Related]

  • 34. [Clinical laboratory approach for estimating effective administrative dose of cefoperazone. Evaluation of disc susceptibility test and its interpretation system].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1988 Oct 27; 41(10):1418-29. PubMed ID: 3204655
    [Abstract] [Full Text] [Related]

  • 35. Spectrum of activity of azithromycin.
    Williams JD.
    Eur J Clin Microbiol Infect Dis; 1991 Oct 27; 10(10):813-20. PubMed ID: 1662624
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
    Bauernfeind A, Jungwirth R, Schweighart S.
    J Antimicrob Chemother; 1989 Sep 27; 24 Suppl A():73-84. PubMed ID: 2509418
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of pH, inoculum size, and incubation time on the susceptibility of Ureaplasma urealyticum to erythromycin in vitro.
    Kenny GE, Cartwright FD.
    Clin Infect Dis; 1993 Aug 27; 17 Suppl 1():S215-8. PubMed ID: 8399919
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.